PEREGRINE CAPITAL MANAGEMENT LLC Cytokinetics, Incorporated Transaction History

PEREGRINE CAPITAL MANAGEMENT LLC portfolio value:

$7.21M
portfolio value

PEREGRINE CAPITAL MANAGEMENT LLC quarter portfolio value change:

+23.31%
quarter

Cytokinetics, Incorporated 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -14.70% -25.65K shares 355K $48.45 148.83K
Q2 2022 share Decrease -20.52% -45.04K shares -1.22M $39.29 174.49K
Q1 2022 share Increase +1.46% 3.16K shares -1.78M $36.81 219.54K
Q4 2021 share Decrease -25.00% -72.11K shares -448K $45.6 216.38K
Q3 2021 share Decrease -31.99% -135.67K shares 1.91M $35.74 288.49K
Q2 2021 share Decrease -5.01% -22.37K shares -1.99M $19.79 424.17K
Q1 2021 share Decrease -19.64% -109.13K shares -1.16M $23.26 446.55K
Q4 2020 share Increase 0.00% 555.68K shares 11.54M $20.78 555.68K